Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study
about
Behavioral and psychological symptoms of dementiaLongitudinal course of behavioural and psychological symptoms of dementia: systematic reviewAmyloid positron emission tomography and cognitive reserveEffect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007-2012.Life Course Trajectories of Later-Life Cognitive Functions: Does Social Engagement in Old Age Matter?Caregiver personality predicts rate of cognitive decline in a community sample of persons with Alzheimer's disease. The Cache County Dementia Progression Study.Affect Balance and Relationship With Well-Being in Nursing Home Residents With Dementia.The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onsetMild cognitive impairment: statistical models of transition using longitudinal clinical dataThe association of traumatic brain injury with rate of progression of cognitive and functional impairment in a population-based cohort of Alzheimer's disease: the Cache County Dementia Progression StudyNon-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect.Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression studyInteraction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's diseasePlasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer's diseaseNeuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression StudyAPOEε2 is associated with milder clinical and pathological Alzheimer disease.Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).Dementia severity and the longitudinal costs of informal care in the Cache County populationAlzheimer's disease: a clinical practice-oriented review.Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progressionNeuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment.The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.Caregivers' relationship closeness with the person with dementia predicts both positive and negative outcomes for caregivers' physical health and psychological well-beingA profile of The Clinical Course of Cognition and Comorbidity in Mild Cognitive Impairment and Dementia Study (The 4C study): two complementary longitudinal, clinical cohorts in the Netherlands.Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease.Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study.Long-term PM2.5 Exposure and Neurological Hospital Admissions in the Northeastern United States.Predictors of quality of life ratings for persons with dementia simultaneously reported by patients and their caregivers: the Cache County (Utah) StudyNeuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression StudySex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.Dementia caregivers' coping strategies and their relationship to health and well-being: the Cache County StudyProgression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scoresEmpirically Defining Trajectories of Late-Life Cognitive and Functional Decline.Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's diseaseCoupled cognitive and functional change in Alzheimer's disease and the influence of depressive symptomsIntravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial.Predictors of progression to severe Alzheimer's disease in an incidence sample.
P2860
Q21129432-B820A687-D7FD-4FC6-A050-B5EA74DCA108Q26739029-4B4EE90E-D2D7-4458-813E-B5A0B3A851B8Q26769755-D67FE6B5-5E76-476E-BD9E-E98D9B285FEEQ31170643-DF841BED-EC14-40A2-AEC7-FC4650E06CB9Q33616171-1F2B55C1-89B6-471E-BD13-C59E59A2E091Q33703732-DA178B1C-419D-4291-99CC-DB0A83418ADDQ33864765-B714B753-0263-4925-AC0A-DF17A5F6ECFBQ33873941-CFDEE234-AC6D-4426-BC06-79AC77DB22FFQ34247588-95272031-5EC1-459B-8E81-003870C77151Q34269094-4C21383D-0C71-487C-BD6F-44DD3AD50E53Q34460952-7F5B4D18-7C16-4AAF-838B-22F8CF0AE7A0Q35093675-D03E3594-7377-4911-B77F-D6EBB3012CC3Q35189449-1BE49FCF-9942-44C1-B264-602FE13EB2ECQ35555867-828C99A2-7164-4B17-A02A-472C05BCCAFEQ35559314-F5DDBDE0-266A-45A3-B80E-0065763B20D7Q35561413-2B42B18D-8E38-45E0-B647-2CEAD172ED8AQ35660968-E9C5BBFA-9288-458F-BBA4-40DCF4BC9F59Q35693632-F290AE5B-2F72-4256-A524-DC0362F7D6D6Q35864658-2986407B-BEB3-44FC-A319-94EB1445B180Q35899503-33D67799-E16C-47A1-B831-8B6A63C66D32Q35925880-D67780C5-9BCD-42B8-90E2-49DF8ACBB1F2Q36093740-FCC110DE-C91C-463E-88D7-1C9326751D75Q36149767-6D6970B3-6E4C-4327-8C3A-6FCA2301D398Q36199048-35619FCD-1E2C-4D5D-81CA-465F16303CDAQ36203534-9D0580ED-CAA8-470D-BE17-33D33EFBC101Q36247013-EB2F13F4-5E44-4C5E-AAFE-FD3298F5ED22Q36252668-1D4F48AF-B674-4F82-A787-4BA7C3637684Q36412958-DBF7F153-670E-426E-8D5E-7F974DC6C4DAQ36456166-532C1CE7-E743-4868-9718-68E5F1CE4444Q36470773-F4DC28FF-52E3-490D-B785-EE8AC30E13AFQ36547529-2E005D6F-F8BC-4B65-B0AC-0C7093C44CFEQ36613964-DDC48E46-578F-4835-8A14-536687A67942Q36758718-5867862F-0D9D-4F9E-B6F2-B8A9FCF6264BQ36837320-3EB61430-D309-4F31-9B41-F3F539C3A608Q36863807-E7B5497E-163F-4857-A74A-968D2145A4B9Q37053816-C33B5A57-F313-47CE-A490-71BFA71EAA19Q37062425-C548B8D3-3DFE-4E88-972D-F641E0954A4AQ37158944-6C2F2BC6-C3D6-4EEC-80EF-2FCCA8383661Q37179956-D2FF369C-A984-408A-B45A-5C1CF7BDB909Q37218809-368A4CDD-21E7-48AA-93E2-418D2002B91F
P2860
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Progression of cognitive, func ...... nty Dementia Progression study
@ast
Progression of cognitive, func ...... nty Dementia Progression study
@en
type
label
Progression of cognitive, func ...... nty Dementia Progression study
@ast
Progression of cognitive, func ...... nty Dementia Progression study
@en
prefLabel
Progression of cognitive, func ...... nty Dementia Progression study
@ast
Progression of cognitive, func ...... nty Dementia Progression study
@en
P2093
P2860
P50
P1476
Progression of cognitive, func ...... nty Dementia Progression study
@en
P2093
Chris D Corcoran
Constantine G Lyketsos
Jeanne-Marie Leoutsakos
JoAnn T Tschanz
John C S Breitner
Katherine Treiber
Kathleen A Welsh-Bohmer
Kathleen Piercy
Maria C Norton
Peter V Rabins
P2860
P304
P356
10.1097/JGP.0B013E3181FAEC23
P577
2011-06-01T00:00:00Z